Contacts

Phase I/II non-randomized, controlled trial, evaluating the safety and efficacy of neurotrophin therapy delivered during cochlear implant surgery

Clinical Trial Contacts

Gary Housley Cathy Birman

Prof. Gary Housley
Chief Lead Investigator
Director, Translational Neuroscience Facility, UNSW Sydney

E: g.housley@unsw.edu.au
W: Translational Neuroscience Facility | School of Biomedical Sciences - UNSW Sydney

Cln Prof. Catherine Birman
Clinical Chief Lead Investigator
NextSense Cochlear Implant Program Medical Director, Gladesville

W: https://www.nextsense.org.au/professional-education/our-teachers/professor-catherine-birman

Mayryl Duxbury

Mayryl Duxbury
Clinical Trial Manager
Translational Neuroscience Facility, UNSW Sydney

E: m.duxbury@unsw.edu.au
W: Translational Neuroscience Facility | School of Biomedical Sciences - UNSW Sydney